Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jun 1;97(11):2585–2592. doi: 10.1172/JCI118707

Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters.

I Hardardóttir 1, A H Moser 1, J Fuller 1, C Fielding 1, K Feingold 1, C Grünfeld 1
PMCID: PMC507345  PMID: 8647952

Abstract

Endotoxin alters the metabolism of lipoproteins, including that of high density lipoprotein (HDL). Cholesteryl ester transfer protein (CETP) facilitates exchange of HDL cholesterol for very low density lipoprotein (VLDL) triglyceride, leading to catabolism of HDL. We investigated the effects of endotoxin and cytokines on CETP in Syrian hamsters. Endotoxin induced a rapid and progressive decrease in serum CETP levels, by 48 h CETP had decreased to < 20% of control levels. Endotoxin also decreased CETP mRNA and protein levels in adipose tissue, heart, and muscle, the tissues with highest levels of CETP mRNA, providing a plausible mechanism for the endotoxin-induced decrease in circulating CETP. Dexamethasone did not mimic the effects of endotoxin on CETP, but the combination of tumor necrosis factor and interleukin-1 did, indicating that these cytokines may in part mediate the effects of endotoxin on CETP. The endotoxin-induced decrease in CETP may help maintain HDL cholesterol levels during infection and inflammation when increased triglyceride levels could drive the exchange of HDL cholesteryl ester for VLDL triglyceride. Maintaining circulating HDL may be important because HDL protects against the toxic effects of endotoxin and provides cholesterol for peripheral cells involved in the immune response and tissue repair.

Full Text

The Full Text of this article is available as a PDF (231.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agellon L. B., Walsh A., Hayek T., Moulin P., Jiang X. C., Shelanski S. A., Breslow J. L., Tall A. R. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem. 1991 Jun 15;266(17):10796–10801. [PubMed] [Google Scholar]
  2. Albrink M. J., Krauss R. M., Lindgrem F. T., von der Groeben J., Pan S., Wood P. D. Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population. Lipids. 1980 Sep;15(9):668–676. doi: 10.1007/BF02534017. [DOI] [PubMed] [Google Scholar]
  3. Au-Young J., Fielding C. J. Synthesis and secretion of wild-type and mutant human plasma cholesteryl ester transfer protein in baculovirus-transfected insect cells: the carboxyl-terminal region is required for both lipoprotein binding and catalysis of transfer. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4094–4098. doi: 10.1073/pnas.89.9.4094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Auerbach B. J., Parks J. S. Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin: cholesterol acyltransferase and lipase deficiency. J Biol Chem. 1989 Jun 15;264(17):10264–10270. [PubMed] [Google Scholar]
  5. Barrans A., Collet X., Barbaras R., Jaspard B., Manent J., Vieu C., Chap H., Perret B. Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem. 1994 Apr 15;269(15):11572–11577. [PubMed] [Google Scholar]
  6. Baumann H., Richards C., Gauldie J. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J Immunol. 1987 Dec 15;139(12):4122–4128. [PubMed] [Google Scholar]
  7. Brown M. L., Inazu A., Hesler C. B., Agellon L. B., Mann C., Whitlock M. E., Marcel Y. L., Milne R. W., Koizumi J., Mabuchi H. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 1989 Nov 23;342(6248):448–451. doi: 10.1038/342448a0. [DOI] [PubMed] [Google Scholar]
  8. Castro G. R., Fielding C. J. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry. 1988 Jan 12;27(1):25–29. doi: 10.1021/bi00401a005. [DOI] [PubMed] [Google Scholar]
  9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  10. Clarke C. F., Edwards P. A., Lan S. F., Tanaka R. D., Fogelman A. M. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA levels in rat liver. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3305–3308. doi: 10.1073/pnas.80.11.3305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ettinger W. H., Miller L. D., Albers J. J., Smith T. K., Parks J. S. Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: cholesterol acyltransferase in cynomolgus monkeys. J Lipid Res. 1990 Jun;31(6):1099–1107. [PubMed] [Google Scholar]
  12. Feingold K. R., Hardardottir I., Memon R., Krul E. J., Moser A. H., Taylor J. M., Grunfeld C. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J Lipid Res. 1993 Dec;34(12):2147–2158. [PubMed] [Google Scholar]
  13. Feingold K. R., Staprans I., Memon R. A., Moser A. H., Shigenaga J. K., Doerrler W., Dinarello C. A., Grunfeld C. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res. 1992 Dec;33(12):1765–1776. [PubMed] [Google Scholar]
  14. Francone O. L., Gurakar A., Fielding C. Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol. J Biol Chem. 1989 Apr 25;264(12):7066–7072. [PubMed] [Google Scholar]
  15. Goldberg I. J., Blaner W. S., Vanni T. M., Moukides M., Ramakrishnan R. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J Clin Invest. 1990 Aug;86(2):463–473. doi: 10.1172/JCI114732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hall-Angerås M., Angerås U., Zamir O., Hasselgren P. O., Fischer J. E. Interaction between corticosterone and tumor necrosis factor stimulated protein breakdown in rat skeletal muscle, similar to sepsis. Surgery. 1990 Aug;108(2):460–466. [PubMed] [Google Scholar]
  17. Hardardóttir I., Grünfeld C., Feingold K. R. Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol. 1994 Jun;5(3):207–215. doi: 10.1097/00041433-199405030-00008. [DOI] [PubMed] [Google Scholar]
  18. Hardardóttir I., Kunitake S. T., Moser A. H., Doerrler W. T., Rapp J. H., Grünfeld C., Feingold K. R. Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters. J Clin Invest. 1994 Sep;94(3):1304–1309. doi: 10.1172/JCI117449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hardardóttir I., Moser A. H., Memon R., Grünfeld C., Feingold K. R. Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res. 1994 Jun;13(3):161–166. [PubMed] [Google Scholar]
  20. Harris H. W., Grunfeld C., Feingold K. R., Rapp J. H. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest. 1990 Sep;86(3):696–702. doi: 10.1172/JCI114765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hayek T., Chajek-Shaul T., Walsh A., Agellon L. B., Moulin P., Tall A. R., Breslow J. L. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels. J Clin Invest. 1992 Aug;90(2):505–510. doi: 10.1172/JCI115887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hoffman J. S., Benditt E. P. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance. J Clin Invest. 1983 Apr;71(4):926–934. doi: 10.1172/JCI110847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Iglesias A., Contreras J. A., Martínez-Pardo M., Entrala A., Herrera E., Lasunción M. A. Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias. Clin Chim Acta. 1993 Nov 30;221(1-2):73–89. doi: 10.1016/0009-8981(93)90023-w. [DOI] [PubMed] [Google Scholar]
  24. Jiang X. C., Moulin P., Quinet E., Goldberg I. J., Yacoub L. K., Agellon L. B., Compton D., Schnitzer-Polokoff R., Tall A. R. Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem. 1991 Mar 5;266(7):4631–4639. [PubMed] [Google Scholar]
  25. Kawakami M., Murase T., Itakura H., Yamada N., Ohsawa N., Takaku F. Lipid metabolism in endotoxic rats: decrease in hepatic triglyceride lipase activity. Microbiol Immunol. 1986;30(9):849–854. doi: 10.1111/j.1348-0421.1986.tb03012.x. [DOI] [PubMed] [Google Scholar]
  26. Kisilevsky R., Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest. 1992 Jun;66(6):778–785. [PubMed] [Google Scholar]
  27. Levine D. M., Parker T. S., Donnelly T. M., Walsh A., Rubin A. L. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12040–12044. doi: 10.1073/pnas.90.24.12040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ly H., Francone O. L., Fielding C. J., Shigenaga J. K., Moser A. H., Grunfeld C., Feingold K. R. Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J Lipid Res. 1995 Jun;36(6):1254–1263. [PubMed] [Google Scholar]
  29. Magilavy D. B., Zhan R., Black D. D. Modulation of murine hepatic lipase activity by exogenous and endogenous Kupffer-cell activation. Biochem J. 1993 May 15;292(Pt 1):249–252. doi: 10.1042/bj2920249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Masucci-Magoulas L., Moulin P., Jiang X. C., Richardson H., Walsh A., Breslow J. L., Tall A. Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice. J Clin Invest. 1995 Apr;95(4):1587–1594. doi: 10.1172/JCI117832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Memon R. A., Grunfeld C., Moser A. H., Feingold K. R. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology. 1993 May;132(5):2246–2253. doi: 10.1210/endo.132.5.8477669. [DOI] [PubMed] [Google Scholar]
  32. Meraïhi Z., Lutz O., Scheftel J. M., Frey A., Ferezou J., Bach A. C. Decreased lipolytic activity in tissues during infectious and inflammatory stress. Nutrition. 1991 Mar-Apr;7(2):93–98. [PubMed] [Google Scholar]
  33. Morrow J. F., Stearman R. S., Peltzman C. G., Potter D. A. Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4718–4722. doi: 10.1073/pnas.78.8.4718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Nonogaki K., Moser A. H., Feingold K. R., Grunfeld C. Alpha-adrenergic receptors mediate the hypertriglyceridemia induced by endotoxin, but not tumor necrosis factor, in rats. Endocrinology. 1994 Dec;135(6):2644–2650. doi: 10.1210/endo.135.6.7988454. [DOI] [PubMed] [Google Scholar]
  35. Okusawa S., Gelfand J. A., Ikejima T., Connolly R. J., Dinarello C. A. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest. 1988 Apr;81(4):1162–1172. doi: 10.1172/JCI113431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Orlinska U., Newton R. C. Role of glucose in interleukin-1 beta production by lipopolysaccharide-activated human monocytes. J Cell Physiol. 1993 Oct;157(1):201–208. doi: 10.1002/jcp.1041570126. [DOI] [PubMed] [Google Scholar]
  37. Parker T. S., Levine D. M., Chang J. C., Laxer J., Coffin C. C., Rubin A. L. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun. 1995 Jan;63(1):253–258. doi: 10.1128/iai.63.1.253-258.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Parthasarathy S., Barnett J., Fong L. G. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990 May 22;1044(2):275–283. doi: 10.1016/0005-2760(90)90314-n. [DOI] [PubMed] [Google Scholar]
  39. Quig D. W., Arbeeny C. M., Zilversmit D. B. Effects of hyperlipidemias in hamsters on lipid transfer protein activity and unidirectional cholesteryl ester transfer in plasma. Biochim Biophys Acta. 1991 Jun 3;1083(3):257–264. doi: 10.1016/0005-2760(91)90080-2. [DOI] [PubMed] [Google Scholar]
  40. Quinet E. M., Huerta P., Nancoo D., Tall A. R., Marcel Y. L., McPherson R. Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence. J Lipid Res. 1993 May;34(5):845–852. [PubMed] [Google Scholar]
  41. Sammalkorpi K., Valtonen V., Kerttula Y., Nikkilä E., Taskinen M. R. Changes in serum lipoprotein pattern induced by acute infections. Metabolism. 1988 Sep;37(9):859–865. doi: 10.1016/0026-0495(88)90120-5. [DOI] [PubMed] [Google Scholar]
  42. Schaefer E. J., Levy R. I., Anderson D. W., Danner R. N., Brewer H. B., Jr, Blackwelder W. C. Plasma-triglycerides in regulation of H.D.L.-cholesterol levels. Lancet. 1978 Aug 19;2(8086):391–393. doi: 10.1016/s0140-6736(78)91863-9. [DOI] [PubMed] [Google Scholar]
  43. Spolarics Z., Pekala P. H., Bagby G. J., Spitzer J. J. Brief endotoxemia markedly increases expression of GLUT1 glucose transporter in Kupffer, hepatic endothelial and parenchymal cells. Biochem Biophys Res Commun. 1993 Jun 30;193(3):1211–1215. doi: 10.1006/bbrc.1993.1754. [DOI] [PubMed] [Google Scholar]
  44. Spolarics Z., Spitzer J. J. Acute endotoxin tolerance is accompanied by stimulated glucose use in macrophage rich tissues. Biochem Biophys Res Commun. 1995 Jun 6;211(1):340–346. doi: 10.1006/bbrc.1995.1816. [DOI] [PubMed] [Google Scholar]
  45. Steinbrecher U. P., Witztum J. L., Parthasarathy S., Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 1987 Mar-Apr;7(2):135–143. doi: 10.1161/01.atv.7.2.135. [DOI] [PubMed] [Google Scholar]
  46. Tall A. R. Plasma cholesteryl ester transfer protein. J Lipid Res. 1993 Aug;34(8):1255–1274. [PubMed] [Google Scholar]
  47. Yamashita S., Matsuzawa Y., Okazaki M., Kako H., Yasugi T., Akioka H., Hirano K., Tarui S. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. Atherosclerosis. 1988 Mar;70(1-2):7–12. doi: 10.1016/0021-9150(88)90094-9. [DOI] [PubMed] [Google Scholar]
  48. Zamir O., Hasselgren P. O., Kunkel S. L., Frederick J., Higashiguchi T., Fischer J. E. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg. 1992 Feb;127(2):170–174. doi: 10.1001/archsurg.1992.01420020052008. [DOI] [PubMed] [Google Scholar]
  49. Zamir O., Hasselgren P. O., von Allmen D., Fischer J. E. In vivo administration of interleukin-1 alpha induces muscle proteolysis in normal and adrenalectomized rats. Metabolism. 1993 Feb;42(2):204–208. doi: 10.1016/0026-0495(93)90036-n. [DOI] [PubMed] [Google Scholar]
  50. Zamir O., Hasselgren P. O., von Allmen D., Fischer J. E. The effect of interleukin-1 alpha and the glucocorticoid receptor blocker RU 38486 on total and myofibrillar protein breakdown in skeletal muscle. J Surg Res. 1991 Jun;50(6):579–583. doi: 10.1016/0022-4804(91)90045-n. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES